GelStat Corp
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and G… Read more
Market Cap & Net Worth: GelStat Corp (GSAC)
GelStat Corp (PINK:GSAC) has a market capitalization of $2.78 ($2.78) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38156 globally and #12418 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GelStat Corp's stock price $0.00 by its total outstanding shares 9273 (9.27K).
GelStat Corp Market Cap History: 2015 to 2025
GelStat Corp's market capitalization history from 2015 to 2025. Data shows change from $74.18 to $2.78 (-31.67% CAGR).
GelStat Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GelStat Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
GelStat Corp's market cap is 0.00 times its annual revenue
24.50x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $13.91 | $201.00K | $175.00K | 0.00x | 0.00x |
| 2020 | $36.16 | $3.95K | -$177.84K | 0.01x | N/A |
| 2021 | $102.93 | $7.02K | -$475.00K | 0.01x | N/A |
| 2022 | $8.35 | $2.33K | -$761.00K | 0.00x | N/A |
| 2023 | $2.78 | $149.53K | -$210.11K | 0.00x | N/A |
| 2024 | $3.71 | $349.73K | -$373.00K | 0.00x | N/A |
Competitor Companies of GSAC by Market Capitalization
Companies near GelStat Corp in the global market cap rankings as of March 18, 2026.
Key companies related to GelStat Corp by market ranking:
- Microsoft Corporation (NASDAQ:MSFT): Ranked #5 globally with a market cap of $2.96 Trillion USD.
- Palantir Technologies Inc. Class A Common Stock (NYSE:PLTR): Ranked #39 globally with a market cap of $324.25 Billion USD.
- Palantir Technologies Inc. (NASDAQ:PLTR): Ranked #40 globally with a market cap of $321.50 Billion USD.
- Oracle Corporation (NYSE:ORCL): Ranked #53 globally with a market cap of $263.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5 | Microsoft Corporation | NASDAQ:MSFT | $2.96 Trillion | $399.41 |
| #39 | Palantir Technologies Inc. Class A Common Stock | NYSE:PLTR | $324.25 Billion | $178.15 |
| #40 | Palantir Technologies Inc. | NASDAQ:PLTR | $321.50 Billion | $155.08 |
| #53 | Oracle Corporation | NYSE:ORCL | $263.97 Billion | $154.69 |
GelStat Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, GelStat Corp's market cap moved from $74.18 to $ 2.78, with a yearly change of -31.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.78 | -25.00% |
| 2024 | $3.71 | +33.33% |
| 2023 | $2.78 | -66.67% |
| 2022 | $8.35 | -91.89% |
| 2021 | $102.93 | +184.62% |
| 2020 | $36.16 | +160.00% |
| 2019 | $13.91 | -50.00% |
| 2018 | $27.82 | -50.00% |
| 2017 | $55.64 | +215.79% |
| 2016 | $17.62 | -76.25% |
| 2015 | $74.18 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GelStat Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.78 USD |
| MoneyControl | $2.78 USD |
| MarketWatch | $2.78 USD |
| marketcap.company | $2.78 USD |
| Reuters | $2.78 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.